… for COVID-19, especially for severe cases. An approach of regenerative medicine by infusion
of stem cells for treating lung diseases … The immense capacity of mesenchymal stem cells (…

… This article reviewed, at the current day, the research progress on stem cell therapy in
COVID-19 patients, and in particular focused on the clinical research status of MSCs and AD-…

… stem cells, includes a medical condition such as lymphoid … umbilical cord stem cells in a
patient with COVID-19 infection … with respiratory failure and COVID-19 severe viral pneumonia …

… of mesenchymal stem cells (MSCs) into patients affected by coronavirus disease 2019 (COVID-19). …
treatment for COVID-19 pneumonia, a severe acute respiratory illness caused by the …

… from cell therapy [6]. Thus, this study aims to review the outcomes of ongoing clinical studies
on stem cells in … The results will be associated with possible applications to COVID-19. …

… COVID-19 disease has been a global health problem since … the effect of stem cell-based
strategies for COVID-19 treatment … “stem cell biology,” “immunomodulatory effects of stem cells,” …

… Defining the underlying pathogenesis and pathology of COVID-19 disease for … disease.
Autopsy and minimally invasive biopsy studies indicate that COVID-19 is a multi-system disease. …

… syndrome (ARDS). Recently, the application of MSCs in the context of ongoing COVID-19
disease and other viral respiratory illnesses … Adipose-derived stem cells (ASC), an abundant …

… for this disease has been … COVID-19 as the most dangerous phase of this disease can be
helpful for the treatment and reduction of the death rate. In this regard, mesenchymal stem cells …

… toward COVID-19 disease. Recent clinical trials outcomes, with use of MSCs for COVID-19
will be analyzed. It seems that expanded umbilical cord mesenchymal stem cells (UC-MSCs) …